The management of women with ductal carcinoma in situ of the breast in Australia and New Zealand between 2007 and 2016
ANZ Journal of Surgery2021Vol. 91(9), pp. 1784–1791
Citations Over Time
Sofia Omling, Nehmat Houssami, Kevin McGeechan, Sophia Zackrisson, Gemma Jacklyn, David J. Walters, Alexandra Barratt, Rachel Farber
Abstract
The clinical management of women diagnosed with DCIS in Australia and New Zealand, appears stable over time. A substantial proportion of women with DCIS receive SNB and this aspect of surgical care warrants further exploration to determine whether it represents appropriate care. These results, alongside the outcomes of the ongoing clinical trials on the management of DCIS, will help inform if any changes to best practice treatment are required.
Related Papers
- → The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study(2017)18 cited
- → Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma In Situ(2007)50 cited
- → Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?(2016)16 cited
- → When is Sentinel Lymph Node Biopsy Useful in Ductal Carcinoma In Situ? The Experience at a Latin American Cancer Center(2021)4 cited